Literature DB >> 12825114

Epidemiological survey on the route of Coxiella burnetii infection in an animal hospital.

Tomoyoshi Komiya1, Kenji Sadamasu, Hiroko Toriniwa, Kimitoshi Kato, Yasutomo Arashima, Hideto Fukushi, Katsuya Hirai, Yasuyuki Arakawa.   

Abstract

The source of Q fever infection, was investigated by serological and polymerase chain reaction (PCR) analysis of specimens from humans and pets in an animal hospital. Two animal health technicians showed a positive serological reaction against Coxiella burnetiiat the start. One of the two positive subjects remained PCR-positive for about 1 year and the other converted to PCR-negative, but the IgG antibody titer remained at 1 : 128 after minocycline treatment. Among animals housed in the hospital, two dogs were PCR-positive at the start, and the infection was transmitted to three cats about 5 months later. All these animals became negative for C. burnetii DNA after minocycline treatment. Furthermore, C. burnetii was isolated from the sera of the two humans and two dogs. C. burnetiiisolates from the humans and dogs were analyzed, and it was found that the sequence homology of the com1 region was high, 99.9%, and the QpH1 plasmid was detected. These results suggest that these isolates were the same type, and it was considered that the infection was derived from the dogs, though the time of infection could not be confirmed.

Entities:  

Mesh:

Year:  2003        PMID: 12825114     DOI: 10.1007/s10156-003-0237-7

Source DB:  PubMed          Journal:  J Infect Chemother        ISSN: 1341-321X            Impact factor:   2.211


  8 in total

1.  Seroprevalence of Coxiella burnetii antibodies among students of the Faculty of Medicine in Kosice (Slovakia).

Authors:  E Dorko; Z Kalinová; E Pilipcinec
Journal:  Folia Microbiol (Praha)       Date:  2009-04-18       Impact factor: 2.099

2.  Seroprevalence and Risk Factors for Coxiella burnetii in Jordan.

Authors:  Mohammad M Obaidat; Lile Malania; Paata Imnadze; Amira A Roess; Alaa E Bani Salman; Ryan J Arner
Journal:  Am J Trop Med Hyg       Date:  2019-07       Impact factor: 2.345

3.  Enhanced detection of Coxiella burnetii with a complementary locked primer-based real-time PCR method.

Authors:  Eun-Ju Kim; Hong Yong Kang; Kyu-Jam Hwang; Sang-Hee Park; Mi-Yeoun Park; Sungdo Park; Jin Seok Yu; Ji Sung Park; Sang Hyeon Kang; Hyuk Chu
Journal:  Mol Diagn Ther       Date:  2011-04-01       Impact factor: 4.074

4.  Q Fever Knowledge, Attitudes and Vaccination Status of Australia's Veterinary Workforce in 2014.

Authors:  Emily Sellens; Jacqueline M Norris; Navneet K Dhand; Jane Heller; Lynne Hayes; Heather F Gidding; Harold Willaby; Nicholas Wood; Katrina L Bosward
Journal:  PLoS One       Date:  2016-01-12       Impact factor: 3.240

5.  Willingness of veterinarians in Australia to recommend Q fever vaccination in veterinary personnel: Implications for workplace health and safety compliance.

Authors:  Emily Sellens; Jacqueline M Norris; Navneet K Dhand; Jane Heller; Lynne Hayes; Heather F Gidding; Harold Willaby; Nicholas Wood; Katrina L Bosward
Journal:  PLoS One       Date:  2018-06-01       Impact factor: 3.240

Review 6.  [Epidemiology of Q fever in Spain (2018)].

Authors:  J L Pérez-Arellano; C Carranza Rodríguez; C Gutierrez; M Bolaños Rivero
Journal:  Rev Esp Quimioter       Date:  2018-07-19       Impact factor: 1.553

7.  Coxiella burnetii in slaughterhouses in Brazil: A public health concern.

Authors:  Mateus de Souza Ribeiro Mioni; Francisco Borges Costa; Bruna Letícia Devidé Ribeiro; Wanderson Sirley Reis Teixeira; Vanessa Cristina Pelicia; Marcelo Bahia Labruna; Élodie Rousset; Karim Sidi-Boumedine; Richard Thiéry; Jane Megid
Journal:  PLoS One       Date:  2020-10-30       Impact factor: 3.240

8.  Neurotransmitter System-Targeting Drugs Antagonize Growth of the Q Fever Agent, Coxiella burnetii, in Human Cells.

Authors:  Marissa S Fullerton; Punsiri M Colonne; Amanda L Dragan; Katelynn R Brann; Richard C Kurten; Daniel E Voth
Journal:  mSphere       Date:  2021-07-07       Impact factor: 4.389

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.